1Patrono C,Coller B,Dalen JE,et al.Platelet active drugs:the relationships among dose,effectiveness,and side effects.Chest,2001,114[5Suppl]:470S-488S.
2Hankey GJ,Eikelboom JW.Aspirin resistance.May be a cause of recurrent ischemic vascular events in patients taking aspirin.BMJ,2004,328 (7438):477-479.
3Weber AA,Przytulski B,Schanz A,et al.Towards a definition of aspirin resistance:a typological approach.Platelets,2002,13 (1):37 -40.
5Helgason CM,Bolin KM,Hoff JA,et al.Development of aspirin resistance in persons with previous ischemic stroke.Stroke,1994,25(12):2331-2336.
6Antithrombotic Trialists' Collaboration.Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death,myocardial infarction,and stroke in high risk patients.BMJ,2002,324(7329):71-86.
7Vane JR,Bakhle YS,Botting RM.Cyclooxygenase land 2.Annu Rev Pharmacol Toxicol,1998,38:97-120.
8Macchi L,Christiaens L,Brabant S,et al.Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate.Thromb Res,2002,107(122):45-49.
9Morrow JD.The isoprostanes:their quantification as an index of oxidant stress status in vivo.Drug Metab Rev,2000,32(324):377-385.
10Kawasaki T,Ozeki Y,Igawa T,et al.Increased platelet sensitivity to collagen in individuals resistant to low-dose aspirin.Stroke,2000,31(3):591.
2Grotemeyer KH.Effects of acetylsalicylic acid in stroke patients: evidence of nonresponders in a subpopulation of treated patients[].Thrombosis Research.1991
3Hurlen M,Seljeflot I,Arnesen H.The effect of different antithrombotic regimens on platelet aggregation after myocardial infarction[].Scandinavian Cardiovascular Journal.1988
4Vejar M,Fragasso G,Hackett D,et al.Dissociation of platelet activation and spontaneous myocardial ischemia in unstable angina[].Thrombosis and Haemostasis.1990
5Antithrombotic Trialists′Collaboration.Collaborative meta-analysis of randomized trials of antiplatelet therapy for preven-tion of death,myocardial infarction,and stroke in high riskpatients[].British Medical Journal.2002
6Helgason CM,Bolin KM,Hoff JA,et al.Development of aspirin resistance in persons with previousischemic stroke[].Stroke.1994
7Chyatte D,Chen TL.Patterns of failure of aspirin treatment in symtomatic atherosclerotic carotid artery disease[].Neurosurgery.1990
8Buchanan MR,Brister SJ.Individual variation in the effects of ASA on platelet function: implication for the use of ASA clinically[].Canadian Journal of Cardiology.1995
5WU Wen-hui,NARASAKI R,BMAEDA F,et al.Glucosyldiacylglycerol enhances reciprocal activation of plasminogen and prourokinase[J].Bioscience Biotechnology and Biochemistry,2004,68(7):1549-1556.
6DALEN J E.Pulmonary embolism:what have we learned since Virchow.treatment and prevention[J].Chest,2002,122(5):1801-1817.
7DALEN J E.Pulmonary embolism:what have we learned since Virchow.Natural history,pathophysiology,and diagnosis[J].Chest,2002,122(4):1440-1456.
8PENG J P,YAO X S.19 new steroidal saponins from Allium plants:isolation,structural elucidation and effect on blood coagulability[J].Adv Exp Med Biol,1996,404:511-526.
9MOSNIER L O,ZLOKOVIC B V,GRIFFIN J H.The cytoprotective protein C pathway[J].Blood,2007,109(8):3161-3172.
